NALFURAPRANT
Live / Registered — Registered (as of 23 Sept 2025)
What this means for you
Registered since 23 Sept 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98438274
- Registration number
- 7962279
- Mark type
- Stylized text
- Filed
- 07 Mar 2024
- Published for opposition
- 17 Dec 2024
- Registered
- 23 Sept 2025
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of addiction, psychosis
Owner
- Jaywing Therapeutics, Seattle, WA, US
- Jaywing Therapeutics, Seattle, WA, US
- Jaywing Therapeutics, Seattle, WA, US
Prosecution history
- 23 Sept 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Sept 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 Sept 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Sept 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Jul 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 May 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 May 2025 — NON-FINAL ACTION E-MAILED
- 08 May 2025 — SU - NON-FINAL ACTION - WRITTEN
- 23 Apr 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Feb 2025 — USE AMENDMENT FILED
- 23 Apr 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Feb 2025 — TEAS STATEMENT OF USE RECEIVED
- 11 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT